Best GLP-1 Providers in Utah (2026)

See by medication

Looking for a specific GLP-1? Browse Utah providers by drug.

About GLP-1s in Utah

Utah allows telehealth GLP-1 prescribing. Utah Medicaid covers GLP-1s only for type 2 diabetes.

• •Utah's adult obesity rate is 27.6%, among the lowest in the US
• •Utah Medicaid restricts GLP-1 coverage to diabetes
• •Salt Lake City is a growing telehealth market

Top Cities for GLP-1 Treatment in Utah

Telehealth providers ship to all Utah addresses, but demand is highest in these metro areas:

Prefer an in-person clinic? Browse the Utah GLP-1 clinic directory →

GLP-1 Care Access in Utah: The Numbers

Utah has 218 NPI-registered in-person weight-management clinics across 39 cities — 3 with an obesity-medicine taxonomy, 80 endocrinology, and 137 bariatric — alongside 101 telehealth programs that ship to Utah addresses. The cheapest verified ongoing compounded semaglutide price available to Utah residents is $65/mo (tirzepatide: $97/mo). Full methodology and the 50-state table: GLP-1 care access by state.

Insurance & Medicaid in Utah

In Q1 2026, Utah Medicaid reimbursed approximately $7,775,305 across 7,671 GLP-1 prescriptions (all covered indications, gross before rebates — federal SDUD data; full state series here).

Most insurance plans in Utah cover GLP-1s for type 2 diabetes (Ozempic, Mounjaro), but coverage for obesity-only indications (Wegovy, Zepbound) is much more limited and often requires prior authorization. If your insurance won't cover brand-name GLP-1s, compounded semaglutide through telehealth is typically the most affordable option at around $199/mo.

For the exact criteria, drug list, and appeal process, read our Utah Medicaid GLP-1 coverage & prior-authorization guide. For coverage backdoors, Zepbound is FDA-approved for obstructive sleep apnea, and Wegovy for kidney and cardiovascular indications, which some plans cover even when they exclude weight-loss-only use.

Obesity in Utah

According to CDC data, 27.6% of Utah adults have obesity (BMI of 30 or higher). This places Utah at #46 out of 50 states. Access to GLP-1 medications like semaglutide and tirzepatide has expanded significantly through telehealth, helping Utah residents get clinically supervised weight loss treatment from home.

To choose a medication, compare the clinical-trial results behind each drug, see our best semaglutide and tirzepatide provider rankings, or track the next-generation GLP-1 pipeline.

Frequently Asked Questions